GOLPH3 also enhances cancer cell survival if the administered drug is a DNA damage-inducing chemical [29], thus its knockdown might be exploited in combination with these substances to enhance the efficacy of chemotherapy. The gene discussed is GOLPH3; the disease is cancer.